Roche extends deadline for Spark Therapeutics shareholders in $4.8B deal By: Philadelphia Business Journal via Business Journals April 03, 2019 at 10:29 AM EDT Roche received offers representing about 29 percent of Sparks’s outstanding shares before the deadline was extended. Read More >>
